The U.S. Food and Drug Administration announced on May 5, 2026, the authorization of four Glas electronic nicotine delivery system (ENDS) products through the Premarket Tobacco Product Application (PMTA) pathway. The authorized products include Classic Menthol, Fresh Menthol, Gold, and Sapphire e-liquid pods containing 50 mg/ml nicotine derived from tobacco. The authorization marks the FDA’s first approval of non-tobacco and non-menthol flavored ENDS products. The agency concluded that the products met the public health standard due to integrated device access restriction technology designed to prevent youth access. The system requires users to verify age and identity using a government-issued ID, connect the device to a smartphone via Bluetooth, and complete periodic biometric verification checks. The FDA also imposed strict marketing and advertising conditions requiring the company to target only adults aged 21 and older and to monitor and report the effectiveness of youth prevention measures. The agency stated that it may suspend or withdraw authorization if youth usage increases or if public health risks outweigh benefits. With these approvals, the FDA has authorized a total of 45 ENDS products for legal sale in the United States.
Consult
